NL8002096A - Injecteerbare stabiele geneesmiddeloplossing met ontstekingremmende werking. - Google Patents

Injecteerbare stabiele geneesmiddeloplossing met ontstekingremmende werking. Download PDF

Info

Publication number
NL8002096A
NL8002096A NL8002096A NL8002096A NL8002096A NL 8002096 A NL8002096 A NL 8002096A NL 8002096 A NL8002096 A NL 8002096A NL 8002096 A NL8002096 A NL 8002096A NL 8002096 A NL8002096 A NL 8002096A
Authority
NL
Netherlands
Prior art keywords
solution
indole
phosphatidylcholine
water
indomethacin
Prior art date
Application number
NL8002096A
Other languages
English (en)
Dutch (nl)
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of NL8002096A publication Critical patent/NL8002096A/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544Phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8002096A 1979-04-11 1980-04-10 Injecteerbare stabiele geneesmiddeloplossing met ontstekingremmende werking. NL8002096A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19792914789 DE2914789A1 (de) 1979-04-11 1979-04-11 Injizierbare arzneimittel mit entzuendungshemmender wirkung
DE2914789 1979-04-11

Publications (1)

Publication Number Publication Date
NL8002096A true NL8002096A (nl) 1980-10-14

Family

ID=6068138

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8002096A NL8002096A (nl) 1979-04-11 1980-04-10 Injecteerbare stabiele geneesmiddeloplossing met ontstekingremmende werking.

Country Status (14)

Country Link
US (1) US4309420A (de)
JP (1) JPS55147217A (de)
AT (1) AT369650B (de)
AU (1) AU539043B2 (de)
BE (1) BE882732A (de)
CA (1) CA1136048A (de)
CH (1) CH642547A5 (de)
DE (1) DE2914789A1 (de)
FR (1) FR2453646A1 (de)
GB (1) GB2047535B (de)
IT (1) IT1148791B (de)
NL (1) NL8002096A (de)
SE (1) SE451428B (de)
ZA (1) ZA802158B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3042365C2 (de) * 1980-11-10 1987-01-29 Extrakta Strauss GmbH, 2000 Hamburg Flüssige, lecithinhaltige einphasige Mehrstoffsysteme und Verfahren zu ihrer Herstellung
JPS59152348A (ja) * 1983-02-19 1984-08-31 Kaken Pharmaceut Co Ltd ビフエニリルプロピオン酸エステル誘導体およびその製造法
US5196567A (en) * 1983-02-19 1993-03-23 Kaken Pharmaceutical Co., Ltd. Biphenylylpropionic acid derivative, process for preparing the same and pharmaceutical composition containing the same
CA1237670A (en) * 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
JPS601122A (ja) * 1983-06-20 1985-01-07 Green Cross Corp:The ビフエニリルプロピオン酸誘導体脂肪乳剤
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
IT1269569B (it) * 1994-04-22 1997-04-08 Ugo Citernesi Procedimento per la preparazione di complessi fra fosfolipidi e principi attivi utili per la produzione di liposomi e principi attivi e liposomi ottenuti con il procedimento
US5763422A (en) 1995-01-27 1998-06-09 Board Of Regents, The University Of Texas System Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
ATE218872T1 (de) * 1995-01-27 2002-06-15 Univ Texas Verfahren zur erhöhung der therapeutischen wirkung von nsaids und dazu verwendbare zwitterionische phospholipidhaltige zusammensetungen
US5955451A (en) * 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
US20040077604A1 (en) * 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
US9730884B2 (en) 2011-09-29 2017-08-15 Plx Opco Inc. pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
JP2023518822A (ja) 2020-03-26 2023-05-08 ピーエルエックス オプコ インコーポレイテッド pH依存的再構築が可能な医薬キャリア、その製造方法及び使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA725596A (en) * 1960-08-26 1966-01-11 J. Wretlind Arvid Method of preparing intravenously injectable fat emulsions free from side reactions or complications
GB1214515A (en) * 1967-04-11 1970-12-02 Sumitomi Chemical Company Ltd Indole derivatives and salts thereof
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
US4093733A (en) * 1976-09-09 1978-06-06 Merck & Co., Inc. Parenteral suspensions
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
DE2856333C2 (de) * 1978-12-27 1983-09-22 A. Nattermann & Cie GmbH, 5000 Köln Oral einnehmbare Arzneimittel mit entzündungshemmender Wirkung

Also Published As

Publication number Publication date
GB2047535B (en) 1983-10-26
JPS55147217A (en) 1980-11-17
DE2914789A1 (de) 1980-10-16
CH642547A5 (de) 1984-04-30
FR2453646B1 (de) 1985-01-25
BE882732A (fr) 1980-07-31
DE2914789C2 (de) 1991-05-29
SE8002715L (sv) 1980-10-12
US4309420A (en) 1982-01-05
AU5733080A (en) 1980-10-16
IT1148791B (it) 1986-12-03
CA1136048A (en) 1982-11-23
FR2453646A1 (fr) 1980-11-07
AT369650B (de) 1983-01-25
GB2047535A (en) 1980-12-03
ATA194780A (de) 1982-06-15
IT8021300A0 (it) 1980-04-10
SE451428B (sv) 1987-10-12
JPH0210805B2 (de) 1990-03-09
AU539043B2 (en) 1984-09-06
ZA802158B (en) 1981-05-27

Similar Documents

Publication Publication Date Title
NL8002097A (nl) Parenteraal toedienbare stabiele geneesmiddel- oplossingen.
NL8002096A (nl) Injecteerbare stabiele geneesmiddeloplossing met ontstekingremmende werking.
US5679690A (en) Concentrated aqueous solutions of argatroban
JP2645427B2 (ja) 混合ミセル溶液
US8426368B2 (en) Method of ameliorating oxidative stress and supplementing the diet
CA1133395A (en) Inflammation-preventing pharmaceutical composition of oral administration
US9592209B2 (en) Method of supplementing the diet and ameliorating oxidative stress
AU749220B2 (en) Lipid complexes and liposomes of highly insoluble platinum complexes
EA006741B1 (ru) Липидная композиция, содержащая производное камптотецина (варианты), способ её получения и применение
PT1477166E (pt) Utilização de riluzole combinado com substâncias auxiliares e aditivos adequados, para o tratamento de doenças caracterizadas por uma hiperproliferação de queratinócitos, especialmente de neurodermite e psoríase
JP2012162577A (ja) がん治療のための細胞増殖抑制剤及び電子受容体を含有する医薬製剤
US20010014695A1 (en) Tryptophanyl-esters and their n-acyl derivatives for preventing and treating diseases caused or aggravated by oxidation processes
PL183040B1 (pl) Kompozycja farmaceutyczna nierozpuszczalnych w wodzie kamptotecyn
KR890000907B1 (ko) 안정한 현탁액 제조용 고체 약물 제형의 제조방법
DE69621773T2 (de) Verfahren zur erhöhung der therapeutischen wirkung von nsaids und dazu verwendbare zwitterionische phospholipidhaltige zusammensetungen
US20030162750A1 (en) Lyophilizate of lipid complex of water insoluble porphyrins
PT92142B (pt) Processo para a preparacao de solucoes parentericas estaveis contendo 2-fenil- -1,2-benzisoselenazol-3 (h)-ona
JP4719355B2 (ja) パルトリシン誘導体の注射可能な薬学的処方物
US20230073803A1 (en) Pharmaceutical composition of cyclooxygenase - 2 inhibitors
PT88309B (pt) Processo para a preparacao de esteres de butilo terciario de drogas anticancerigenas e sua utilizacao para melhorar a administracao das drogas ao cerebro
WO2009025571A1 (en) Sublingual or buccal pharmaceutical compositions comprising succinic acid for treating alzheimer's disease

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed